These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Periodontal disease and risk of non-Hodgkin lymphoma in the Health Professionals Follow-Up Study. Bertrand KA; Shingala J; Evens A; Birmann BM; Giovannucci E; Michaud DS Int J Cancer; 2017 Mar; 140(5):1020-1026. PubMed ID: 27861844 [TBL] [Abstract][Full Text] [Related]
6. Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium. 't Mannetje A; De Roos AJ; Boffetta P; Vermeulen R; Benke G; Fritschi L; Brennan P; Foretova L; Maynadié M; Becker N; Nieters A; Staines A; Campagna M; Chiu B; Clavel J; de Sanjose S; Hartge P; Holly EA; Bracci P; Linet MS; Monnereau A; Orsi L; Purdue MP; Rothman N; Lan Q; Kane E; Costantini AS; Miligi L; Spinelli JJ; Zheng T; Cocco P; Kricker A Environ Health Perspect; 2016 Apr; 124(4):396-405. PubMed ID: 26340796 [TBL] [Abstract][Full Text] [Related]
7. Trans fatty acid intake is associated with increased risk and n3 fatty acid intake with reduced risk of non-hodgkin lymphoma. Charbonneau B; O'Connor HM; Wang AH; Liebow M; Thompson CA; Fredericksen ZS; Macon WR; Slager SL; Call TG; Habermann TM; Cerhan JR J Nutr; 2013 May; 143(5):672-81. PubMed ID: 23486982 [TBL] [Abstract][Full Text] [Related]
8. Association between Meat, Fish, and Fatty Acid Intake and Non-Hodgkin Lymphoma Incidence: The Japan Public Health Center-Based Prospective Study. Shimomura Y; Sobue T; Zha L; Kitamura T; Iwasaki M; Inoue M; Yamaji T; Tsugane S; Sawada N J Nutr; 2022 Aug; 152(8):1895-1906. PubMed ID: 35675313 [TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma. Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221 [TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia. Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728 [TBL] [Abstract][Full Text] [Related]
11. Circulating Very-Long-Chain SFA Concentrations Are Inversely Associated with Incident Type 2 Diabetes in US Men and Women. Ardisson Korat AV; Malik VS; Furtado JD; Sacks F; Rosner B; Rexrode KM; Willett WC; Mozaffarian D; Hu FB; Sun Q J Nutr; 2020 Feb; 150(2):340-349. PubMed ID: 31618417 [TBL] [Abstract][Full Text] [Related]
12. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371 [TBL] [Abstract][Full Text] [Related]
13. Family history of hematopoietic malignancy and risk of lymphoma. Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696 [TBL] [Abstract][Full Text] [Related]
14. A prospective analysis of body size during childhood, adolescence, and adulthood and risk of non-Hodgkin lymphoma. Bertrand KA; Giovannucci E; Zhang SM; Laden F; Rosner B; Birmann BM Cancer Prev Res (Phila); 2013 Aug; 6(8):864-73. PubMed ID: 23803416 [TBL] [Abstract][Full Text] [Related]
15. Erythrocyte membrane fatty acid composition, serum lipids, and non-Hodgkin's lymphoma risk in a nested case-control study: the multiethnic cohort. Morimoto Y; Conroy SM; Ollberding NJ; Henning SM; Franke AA; Wilkens LR; Goodman MT; Hernandez BY; Le Marchand L; Henderson BE; Kolonel LN; Maskarinec G Cancer Causes Control; 2012 Oct; 23(10):1693-703. PubMed ID: 22907421 [TBL] [Abstract][Full Text] [Related]
16. Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis. Rhee J; Birmann BM; De Roos AJ; Epstein MM; Martinez-Maza O; Breen EC; Magpantay LI; Levin LI; Visvanathan K; Hosgood HD; Rohan TE; Smoller SW; Bassig BA; Qi L; Shu XO; Koh WP; Zheng W; Yuan JM; Weinstein SJ; Albanes D; Lan Q; Rothman N; Purdue MP Int J Cancer; 2023 Mar; 152(5):865-878. PubMed ID: 36151863 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype. Abuamsha H; Kadri AN; Hernandez AV Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804 [TBL] [Abstract][Full Text] [Related]
18. Erythrocyte levels of cadmium and lead and risk of B-cell non-Hodgkin lymphoma and multiple myeloma. Deubler EL; Gapstur SM; Diver WR; Gaudet MM; Hodge JM; Stevens VL; McCullough ML; Haines LG; Levine KE; Teras LR Int J Cancer; 2020 Dec; 147(11):3110-3118. PubMed ID: 32506449 [TBL] [Abstract][Full Text] [Related]
19. Outdoor artificial light at night and risk of non-Hodgkin lymphoma among women in the California Teachers Study cohort. Zhong C; Franklin M; Wiemels J; McKean-Cowdin R; Chung NT; Benbow J; Wang SS; Lacey JV; Longcore T Cancer Epidemiol; 2020 Dec; 69():101811. PubMed ID: 33002844 [TBL] [Abstract][Full Text] [Related]